Updated:
The Cooper Companies
CooperCompanies is a global, consumer-centric medical device company that supports how people want to live, at every stage of life. By listening closely to
The Cooper Companies
CooperCompanies is a global, consumer-centric medical device company that supports how people want to live, at every stage of life. By listening closely to
General information
Firm type
other
Location
Region
North America
Country
United States
City
San Ramon
Corporate office
6101 Bollinger Canyon Road, Suite 500, San Ramon, CA 94583, United States
Additional offices
Victor, NY, United States · Trumbull, CT, United States
Sector focus
Frequently asked questions
Who runs investment decisions at The Cooper Companies?
Investment decisions at The Cooper Companies are made by its executive leadership team and board of directors, following corporate governance rules for a publicly traded company. The firm does not have a single family office or CIO making discretionary allocations. The CEO and CFO, along with segment presidents, guide capital deployment across CooperVision and CooperSurgical (per SEC filings).
How does The Cooper Companies source proprietary deal flow?
The firm sources acquisitions through direct outreach by its corporate development team, industry conferences, and relationships with advisors in the medical device and healthcare sectors. It has completed deals like the Generate Life Sciences acquisition. The firm also evaluates internal R&D for organic growth.
Is The Cooper Companies structured as a single family office or does it operate more like a venture firm?
The Cooper Companies is a publicly traded corporation, not a family office or venture firm. It operates under fiduciary duties to public shareholders. Its deployment is entirely corporate — funding internal R&D and M&A within two business segments — rather than managing external LP capital or making venture-style direct investments.
Does The Cooper Companies participate in fund commitments or only direct deals?
The Cooper Companies does not participate as a limited partner in external investment funds. All capital deployment occurs through direct corporate actions: acquisitions, internal R&D projects, and capital expenditures for its operating businesses.
What investment stages does The Cooper Companies typically target?
The firm targets majority acquisitions of established medical device and surgical companies, typically at the growth or mature stage. It does not invest in seed or early-stage startups. Recent deals include the Generate Life Sciences purchase for $875 million.
Which sectors does The Cooper Companies explicitly avoid?
The firm explicitly avoids pharmaceutical, biotech therapeutic, and software-only healthcare sectors. Its focus is strictly medical devices — vision care and surgical — and not drug development or digital health platforms.
Where does the underlying wealth come from?
The Cooper Companies is a publicly traded corporation that generates wealth through sales of contact lenses and surgical products. No private family fortune underlies its entity. Wealth origin is corporate earnings, not an individual or family.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: